MedPath

Research for establishment and validation of therapeutic guideline aiming at "treatment holiday" in rheumatoid arthritis

Phase 4
Conditions
rheumatoid arthritis
Registration Number
JPRN-UMIN000014856
Lead Sponsor
niversity of Occupational and Environmental Health, Japan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
436
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patient with contraindication to MTX. (2) Patient with contraindication to biological DMARD. (3) Patient with any other reasons for inadequate to participate in this study, judege by attending rheumatologist.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DAS28(ESR) remission rate at 1 year after discontinuing biological DMARD
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath